Mark G. Kris, MD, on NSCLC: Juggling Sequence and Agent Choices in Lung Cancer

Posted: Monday, June 4, 2018

Mark G. Kris, MD, of Memorial Sloan Kettering Cancer Center, discusses three key studies on adjuvant vs neoadjuvant chemotherapy, radiotherapy plus chemotherapy, and nivolumab added to radiotherapy—how and when to administer in non–small cell lung cancer.